COVID-19
Researchers from the University of Latvia have conducted a study on the COVID-19 pandemic, highlighting the importance of public attitudes in shaping policy responses to crises. The study, funded by the Academic project 'Innovative and Inclusive Management for the Promotion of Public Involvement, Trust, and Communication', found that
COVID-19
Scientists at the University of Arizona have made significant discoveries regarding the immune responses to SARS-CoV-2 variants, particularly in relation to the Delta and Omicron BA.1 variants. The research found that few type-specific antibodies are produced in response to post-vaccination exposures to these variants, which may be due to
COVID-19
Researchers at Northeastern University have made a groundbreaking discovery in the fight against COVID-19, developing a biochar material that exhibits unparalleled efficiency in adsorbing COVID-19 drug residues. The researchers, led by Ting Sun, discovered that self-doping of biochar with heteroatoms such as boron, nitrogen, and sulfur significantly enhances its electronic
COVID-19
A recent study conducted by the National Hospital Organization Kyoto Medical Center in Japan investigated the impact of the COVID-19 pandemic on tobacco use behavior among Japanese individuals. The researchers found that the pandemic had a significant effect on tobacco use patterns, with more participants achieving cessation after 1 year
COVID-19
A recent study investigating the relationship between complementary medicine (CM) use and COVID-19 vaccination uptake in a nationally representative US sample has found that overall use of CM was not significantly associated with COVID-19 vaccination uptake. However, the study did reveal that individuals who visited chiropractors were less likely to
COVID-19
Investigations into new COVID-19 vaccination strategies have made significant progress, with researchers at Institut Teknologi Bandung developing a multi-epitope peptide-based vaccine that successfully induces immune responses in mice. This breakthrough vaccine targets SARS-CoV-2 structural and non-structural proteins, demonstrating potential to overcome vaccine failure due to viral genetic mutations. Key Takeaways:
COVID-19
Research conducted at the University of Michigan has underscored the significance of post-vaccination experiences in shaping individual and communal attitudes toward vaccines, particularly among healthcare workers in low- and middle-income countries. The study explored the post-vaccination experiences of healthcare workers in Sierra Leone and found that positive vaccination experiences significantly
COVID-19
New research conducted by the Food and Drug Administration (FDA) and published in npj Viruses has highlighted the continuous evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), necessitating periodic updates of vaccine composition. According to the study, immunity acquired through previous infection or vaccination offers protection against antigenically distinct
COVID-19
A study conducted by researchers from Nicklaus Children's Hospital in Miami, Florida, has shed light on the COVID-19 vaccination knowledge, attitudes, and practices among predominantly Hispanic/Latino pediatric healthcare workers. The research aimed to explore the factors influencing vaccine acceptance among this group, with a focus on the
COVID-19
The COVID-19 pandemic led to significant changes in healthcare and education sectors across Canada, particularly affecting children with complex care needs who rely on specialized services. A recent study conducted in the Maritime provinces explores the impact of public health measures on these children and their families, highlighting themes of
COVID-19
Researchers have explored dynamic changes in ADAR expression and editing patterns across three stages of SARS-CoV-2 infection. Forty-five age-matched individuals with no comorbidities developed mild COVID-19 and were sampled across the pre-, mid-, and post-infection stages. The study found dynamic changes in ADAR expression and editing, with unique editing sites
COVID-19
Researchers from the University of Laval conducted a study to investigate the impact of ozanimod, a sphingosine-1-phosphate receptor 1 (S1P1) ligand, on the immune response in patients with severe COVID-19. The study found that ozanimod effectively reduced immunopathological damage by inhibiting cytokine storm and preserving lung endothelial barrier integrity. In
